Skip to content
Archit Organosys logo

Archit Organosys

524640 BSE
₹68.42

Close ·

P/E
18.90
View as Markdown
MCP
Close 4 Nov 2026 ₹68.42 +21.80 +46.8% 1Y
Start ₹46.62

Key Fundamentals

MicrocapChemicals & PetrochemicalsChemicals

Price-based figures at the close · EPS basis: Standalone · TTM

ROCE
13.80%
Debt to Equity
0.32
EPS (TTM)
₹3.62
Book Value
₹37.15
Market Cap
—
P/E (TTM)
18.90
P/B
1.84
ROE
11.40%
Dividend Yield
1.47%
EBITDA
₹9.20 Cr
52W High
₹71.99
52W Low
₹34.00

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

60 Good

Data confidence 100/100

Category scores

Quality
68
Strong
Returns, margins, earnings quality 22% weight
Valuation
52
Average
Cheap vs sector & own history 24% weight
Growth
49
Average
Sales & profit trajectory 9% weight
Financial Health
48
Average
Solvency, leverage, coverage 9% weight
Momentum
94
Strong
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

No strengths listed

Weaknesses

2
  • The company has delivered a poor sales growth of 8.32% over past five years.
  • Company has a low return on equity of 6.84% over last 3 years.

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bullish3412
OscillatorsBearish342
Moving AveragesStrong Bullish0010

Key readings

RSI (14)
65.98
Neutral
MACD (12,26,9)
1.03
Bullish
SMA (50)
64.09
Bullish
SMA (200)
52.80
Bullish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+10.70%
5Y+8.22%
3Y+3.28%
1Y+11.90%
TTM+9.90%

Net profit

Net profit growth by window
10Y+23.11%
5Y+9.86%
3Y−10.07%
1Y+60.00%
TTM+22.17%

Operating cash flow

Operating cash flow growth by window
10Y+11.61%
5Y−22.88%
3Y−44.97%
1Y−84.21%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+6.18 pp
5Y+0.48 pp
3Y−3.57 pp
1Y+1.74 pp
TTM+0.12 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹48.00 Cr
Mar 2018₹82.00 Cr
Mar 2019₹84.00 Cr
Mar 2020₹77.00 Cr
Mar 2021₹95.00 Cr
Mar 2022₹138 Cr
Mar 2023₹128 Cr
Mar 2024₹113 Cr
Mar 2025₹126 Cr
Mar 2026₹141 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹2.00 Cr
Mar 2018₹1.00 Cr
Mar 2019−₹5.00 Cr
Mar 2020−₹1.00 Cr
Mar 2021₹5.00 Cr
Mar 2022₹8.00 Cr
Mar 2023₹11.00 Cr
Mar 2024₹3.00 Cr
Mar 2025₹5.00 Cr
Mar 2026₹8.00 Cr

Quarterly Results

₹ Cr
524640 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
31
26.39
24.81
30.99
27
29.54
25.87
43.18
33.2
32.86
38.4
36.5
37.08
Expenses
27.76
24.28
23.71
30.7
23.95
26.69
23.21
38.76
29.06
30.16
33.72
31.61
33.71
Operating Profit
3.24
2.11
1.1
0.29
3.05
2.85
2.66
4.42
4.14
2.7
4.68
4.89
3.37
OPM %
10.45%
8%
4.43%
0.94%
11.3%
9.65%
10.28%
10.24%
12.47%
8.22%
12.19%
13.4%
9.09%
Other Income
0.71
0.54
0.52
4.11
0.47
0.63
0.93
1.06
1
1.46
0.9
−0.47
0.6
Interest
0.52
0.65
0.77
0.64
0.62
0.78
0.47
0.71
0.6
0.67
0.56
0.46
0.44
Depreciation
1.19
1.49
1.49
1.48
1.49
1.5
1.49
1.46
1.49
1.52
1.52
1.49
1.5
PBT
2.24
0.51
−0.64
2.28
1.41
1.2
1.63
3.31
3.05
1.97
3.5
2.47
2.03
Tax %
26.79%
27.45%
−29.69%
21.49%
29.08%
15%
37.42%
38.67%
33.11%
21.83%
30.86%
18.22%
28.57%
Net Profit
1.64
0.37
−0.46
1.79
1.01
1.02
1.01
2.02
2.04
1.54
2.43
2.02
1.45
EPS (₹)
0.8
0.18
−0.22
0.87
0.49
0.5
0.49
0.98
0.99
0.75
1.18
0.98
0.71

Profit & Loss

₹ Cr
524640 profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
56
51
48
82
84
77
95
138
128
113
126
141
145
Expenses
53
48
44
78
87
73
83
121
108
106
113
124
129
Operating Profit
2
3
4
4
−3
4
11
17
20
7
13
17
16
OPM %
4%
6%
8%
4.6%
−3.6%
4.6%
12%
12%
15%
6%
10%
12%
11%
Other Income
1
1
0
3
3
2
0
1
3
6
3
3
2
Interest
1
1
1
4
4
3
3
2
2
3
3
2
2
Depreciation
0
0
1
3
3
3
4
5
5
6
6
6
6
PBT
1
2
3
0
−6
−1
5
11
15
4
8
11
10
Tax %
43%
37%
42%
−32%
−25%
1%
−7%
28%
26%
24%
33%
27%
—
Net Profit
1
1
2
1
−5
−1
5
8
11
3
5
8
7
EPS (₹)
0.87
0.97
1.14
0.34
−3.14
−0.53
3.34
4.01
5.57
1.63
2.46
3.91
3.62
Div. Payout %
0%
0%
0%
0%
0%
0%
15%
19%
9%
0%
20%
26%
—

Balance Sheet

₹ Cr
524640 balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3
5
10
15
15
15
15
21
21
21
21
21
Reserves
2
8
17
25
20
19
26
31
41
44
49
56
Borrowings
9
11
31
36
37
33
30
34
31
26
28
25
Other Liabilities
10
8
12
26
12
16
17
18
27
18
26
25
Total Liabilities
24
32
70
101
84
83
87
104
120
108
123
127
Fixed Assets
6
6
47
47
47
50
48
45
50
60
54
50
CWIP
0
8
1
8
5
1
3
13
14
1
1
0
Investments
0
0
0
0
0
0
0
1
4
6
6
7
Other Assets
18
18
22
46
32
32
37
44
52
42
62
70
Total Assets
24
32
70
101
84
83
87
104
120
108
123
127

Cash Flow

₹ Cr
524640 cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2
1
2
−4
3
8
11
11
18
10
19
3
Investing
−2
−8
−35
−9
1
−1
−3
−12
−12
−2
−21
4
Financing
1
7
32
13
0
−9
−7
2
−7
−9
−1
−6
Net Cash Flow
0
0
0
0
4
−2
1
2
0
−1
−4
1
Free Cash Flow
0
−7
−32
−13
3
6
8
0
9
15
18
1
CFO/OP
93
57
75
−90
−97
221
99
71
108
164
150
29

Ratios

524640 financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
76
79
86
140
62
94
97
72
107
72
67
64
Inventory Days
28
28
27
41
30
22
21
22
16
16
18
11
Days Payable
72
63
80
126
55
88
87
51
110
62
91
65
Cash Conversion Cycle
33
44
33
56
38
28
30
44
13
26
−6
10
Working Capital Days
−1
3
19
12
−23
−39
−15
0
10
10
45
40
ROCE %
20%
17%
9%
6%
−4%
3%
12%
18%
17%
4%
11%
14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Archit Organosys insights

59 extracted metrics across FY10–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 65.88%
  • Public 30.31%
  • Others 3.81%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Archit Organosys

What does Archit Organosys Ltd do?
Incorporated in 1989, Archit Organosys Ltd does manufacturing and trading of chemicals and organics
Where is Archit Organosys Ltd (ARCHITORG) listed?
Archit Organosys Ltd trades under code 524640 on the BSE.
Which sector does Archit Organosys Ltd belong to?
Archit Organosys Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the PE ratio of Archit Organosys Ltd?
Archit Organosys Ltd trades at a PE ratio of 18.90 as of 4 Nov 2026, on earnings per share of ₹3.62, against a book value of ₹37.15 per share.
What is the 52-week high and low of Archit Organosys Ltd?
Over the last 52 weeks Archit Organosys Ltd has traded between ₹34 and ₹71.99 as of 4 Nov 2026.
Does Archit Organosys Ltd pay dividends?
Archit Organosys Ltd has a dividend yield of 1.47%.
What is the Return on Equity (ROE) of Archit Organosys Ltd?
Archit Organosys Ltd reported a return on equity of 11.40%. Its debt-to-equity ratio is 0.32.

Company Information

Incorporated in 1989, Archit Organosys Ltd does manufacturing and trading of chemicals and organics

Website architorg.com
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524640.md for Archit Organosys Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Chemical & Petrochemical stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month